Target intelligence / Profile preview

Human α7 nicotinic acetylcholine receptor (α7 nAChR)

Target
α7 nAChR
Molecular classification
Receptor, Ligand-gated ion channel, Cys-loop receptor superfamily, Nicotinic acetylcholine receptor (nAChR) subtype, Homopentameric ion channel
01

Overview

The human α7 nicotinic acetylcholine receptor is a homo-pentameric ligand-gated ion channel that belongs to the Cys-loop superfamily. Highly permeable to calcium ions, this receptor plays essential roles in fast synaptic transmission, especially within the central nervous system, modulating cognition, neuroprotection, pain, and the cholinergic inflammatory pathway. Its structural and functional properties—including rapid desensitization—make it an important drug target for neurodegenerative diseases, cognitive impairment, inflammatory conditions, and, paradoxically, certain cancers. Both orthosteric and allosteric drug modulators are under clinical investigation, though fast desensitization and translational gaps—such as the influence of the human-specific CHRFAM7A gene—pose therapeutic challenges.

Other names
α7 nAChRα7 nicotinic receptorα7 receptorNicotinic acetylcholine receptor alpha-7 subunitCHRNA7
02

Mechanism of action

Agonists: Activate the receptor leading to opening of the ion channel and cation (primarily Ca²⁺) influx. Positive allosteric modulators: Increase efficacy or prolong activation of the ligand-gated ion channel in the presence of agonist. Antagonists: Block ion channel opening by competing with endogenous ligands or binding allosteric sites.

03

Biological functions

Signal transductionCognitionMemoryNeuroprotectionPain modulationImmune response/cholinergic anti-inflammatory pathwaySynaptic transmission
04

Disease associations

Neurodegenerative diseases (e.g., Alzheimer's disease, Parkinson's disease)InflammationCognitive disordersPainSchizophreniaCancer (especially cell proliferation in some cancer subtypes)
05

Safety considerations

Desensitization/rapid tolerance (fast onset of receptor desensitization limits therapeutic window)Excitotoxicity/neurotoxicity (excessive activation/hyperstimulation can cause neuronal damage in some settings)Off-target effects/cardiovascular toxicity (especially with non-selective nAChR modulators)Tumor proliferation (increased α7 activity has been linked to cancer cell growth in certain contexts)
06

Interacting drugs

Orthosteric agonists: EVP-6124 (encenicline), DMXB-A (GTS-21), choline, acetylcholine, epibatidine

3 more in the full profile.

07

Biomarkers

CHRNA7 gene expression (including copy number variations of CHRFAM7A, which can modulate receptor function)Receptor protein levels in brain or peripheral tissuesCholinergic pathway activity markersInflammatory cytokines (IL-1β, TNF-α) downstream of receptor activity in disease contexts

Beyond the preview

Go deeper on Human α7 nicotinic acetylcholine receptor (α7 nAChR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human α7 nicotinic acetylcholine receptor (α7 nAChR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call